Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03429114
Other study ID # 40075
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 15, 2017
Est. completion date September 1, 2022

Study information

Verified date December 2022
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study will examine the neural and behavioral correlates of emotion regulation in adolescents engaging in binge eating and/or purging and healthy adolescents. Furthermore, it will look at the influence of executive function on emotion regulation in this population. This study will allow us to gain further understanding of the neural basis of emotion regulation in this age group. Moreover, this study supports the need to develop new treatment approaches based on a better understanding of the brain processes associated with eating disorders.


Recruitment information / eligibility

Status Completed
Enrollment 47
Est. completion date September 1, 2022
Est. primary completion date September 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 14 Years to 18 Years
Eligibility Inclusion Criteria: - Female - Ages 14-18 - with or without current binge eating and/or purging behaviors Exclusion Criteria: We exclude patients of clinically significant low weight (<85% ideal body weight using CDC norms for height, age, and gender) and those with contraindications for MRI (e.g., orthodontia, metallic implants). Participants also will be without evidence of current or past major neurological (e.g., seizures, psychosis, head trauma) or major sensory deficit.

Study Design


Intervention

Other:
Magnetic resonance imaging
We will conduct MRI and fMRI brain scans to compare brain function between groups.

Locations

Country Name City State
United States Stanford University, Department of Psychiatry Stanford California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Brain activity during emotion conflict Functional magnetic resonance imaging will be used to measure brain activity during a task where participants respond to images of faces with emotional expressions overlaid with an emotion word written in text. We will focus on brain response during this task when emotion face vs word are in conflict. Baseline
Primary Brain activity during emotion regulation Functional magnetic resonance imaging will be used to measure brain activity during a task where participants attempt to regulate emotional responses. Baseline
Primary Brain activity during cognitive control and emotion response Functional magnetic resonance imaging will be used to measure brain activity during a task where participants engage in cognitive control and respond to emotional stimuli. Baseline
Secondary Behavioral performance on emotion conflict task Response times will be used as behavioral measure on the emotion conflict task Baseline
Secondary Behavioral performance on emotion regulation task Emotion ratings will be used as behavioral measure on the emotion regulation task Baseline
Secondary Behavioral performance on cognitive control and emotion regulation task Emotion ratings will be used as behavioral measure on the cognitive control and emotion regulation task Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04038190 - A Behavioral Activation Intervention Administered in a College Freshman Orientation Course Phase 2
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Completed NCT00537810 - Treatment of Binge Eating in Obese Patients in Primary Care Phase 4
Recruiting NCT05509257 - Naltrexone Neuroimaging in Teens With Eating Disorders Early Phase 1
Completed NCT03687658 - Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating N/A
Recruiting NCT05937243 - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating N/A
Completed NCT00607789 - Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression Phase 4
Completed NCT04117542 - Working Memory in Overweight Children With and Without Loss of Control Eating
Recruiting NCT04211818 - Analysis of the Glycemic Profile of People Suffering From Compulsive Eating Disorders Aiming to Offer an Innovative Nutritional Approach (GLUCOPULSE) N/A
Completed NCT05041660 - Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating N/A
Completed NCT03007459 - The Health of Competitive Fitness Athletes
Completed NCT02180984 - The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED N/A
Completed NCT00829283 - Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care N/A
Completed NCT00307619 - An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder. Phase 3
Active, not recruiting NCT04127214 - The ITA Model of Integrated Treatment of Eating Disorders
Not yet recruiting NCT06129461 - A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy N/A
Recruiting NCT05177705 - The Intersection Between Loss of Control Eating and Obesity: The Role of Restriction and Food Reinforcement Early Phase 1
Recruiting NCT02716831 - Improving Treatments for Bulimia Nervosa: Innovation in Psychological Interventions for Regulating Eating N/A
Completed NCT03850288 - Inhibitory Control and Eating Disorders
Completed NCT00680979 - Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity Phase 2